These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18685349)

  • 1. Pharmacological management of dyspnoea.
    Currow DC; Abernethy AP
    Curr Opin Support Palliat Care; 2007 Aug; 1(2):96-101. PubMed ID: 18685349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
    Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
    J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the pharmacological management of breathlessness.
    Currow DC; Ward AM; Abernethy AP
    Curr Opin Support Palliat Care; 2009 Jun; 3(2):103-6. PubMed ID: 19333124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
    van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
    BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological therapy of refractory dyspnoea : a systematic literature review].
    Simon ST; Köskeroglu P; Bausewein C
    Schmerz; 2012 Sep; 26(5):515-22. PubMed ID: 22956077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.
    Barnes H; McDonald J; Smallwood N; Manser R
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011008. PubMed ID: 27030166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of opioids on breathlessness and exercise endurance in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis of randomised controlled trials.
    Liu M; Xiao W; Du L; Yu Y; Chen X; Mao B; Fu J
    Palliat Med; 2023 Oct; 37(9):1365-1378. PubMed ID: 37710987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
    Smallwood N; Le B; Currow D; Irving L; Philip J
    Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients.
    Varkey B
    Curr Opin Pulm Med; 2010 Mar; 16(2):150-4. PubMed ID: 20071992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Refractory Dyspnea in Advanced COPD: Palliative Treatment with Opioids].
    Ficker JH; Brückl WM
    Pneumologie; 2019 Jul; 73(7):430-438. PubMed ID: 31291670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.
    Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Hameleers N; Wouters EFM; Janssen DJA
    JAMA Intern Med; 2020 Oct; 180(10):1306-1314. PubMed ID: 32804188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Opioids for refractory dyspnoea in palliation].
    Aabom B; Bendstrup E; Sjøgren P; Løkke A; Shaker B; Wilcke T; Jespersen BA; Hilberg O; Marsaa K
    Ugeskr Laeger; 2020 Sep; 182(40):. PubMed ID: 33000737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic refractory dyspnoea--evidence based management.
    Wiseman R; Rowett D; Allcroft P; Abernethy A; Currow DC
    Aust Fam Physician; 2013 Mar; 42(3):137-40. PubMed ID: 23529525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliation of dyspnoea in advanced COPD: revisiting a role for opioids.
    Rocker G; Horton R; Currow D; Goodridge D; Young J; Booth S
    Thorax; 2009 Oct; 64(10):910-5. PubMed ID: 19786716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.
    Simon ST; Higginson IJ; Booth S; Harding R; Bausewein C
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007354. PubMed ID: 20091630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids for symptomatic therapy of dyspnoea in patients with advanced chronic heart failure--is there evidence?
    Hochgerner M; Fruhwald FM; Strohscheer I
    Wien Med Wochenschr; 2009 Dec; 159(23-24):577-82. PubMed ID: 20151346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease.
    Smallwood N; Gaffney N; Gorelik A; Irving L; Le B; Philip J
    Intern Med J; 2017 Sep; 47(9):1050-1056. PubMed ID: 28585274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of inhaled opioids and furosemide for the treatment of dyspnea.
    Kallet RH
    Respir Care; 2007 Jul; 52(7):900-10. PubMed ID: 17594733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic breathlessness in advanced cardiorespiratory disease: patient perceptions of opioid use.
    Moran T; Zentner D; Wong J; Philip J; Smallwood N
    BMJ Support Palliat Care; 2023 Dec; 13(e2):e334-e343. PubMed ID: 33837113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.